Literature DB >> 7761408

Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection.

T V Golovkina1, J P Dudley, A B Jaffe, S R Ross.   

Abstract

Mouse mammary tumor virus (MMTV) encodes a superantigen that is important for viral infectivity in vivo. To determine whether superantigen function was required for infection by milk-borne MMTV, we created HYB PRO/Cla transgenic mice. These mice produced a full-length, packaged viral RNA with a frameshift mutation that caused premature termination of the superantigen protein. Young HYB PRO/Cla mice showed no deletion of their cognate V beta 14+ T cells, although they shed virus in their milk. The nontransgenic offspring of the HYB PRO/Cla mice were infected with this virus, since transgene-specific viral transcripts were detected in their mammary glands. Surprisingly, these offspring demonstrated the progressive deletion of V beta 14+ T cells characteristic of exogenous MMTV (C3H) infection. Sequence analysis demonstrated that these newly acquired viruses had reconstituted superantigen open reading frames resulting from recombination between the HYB PRO/Cla and endogenous Mtv-1 proviral RNAs. Thus, there is selection during the infection process for MMTVs with functional superantigen genes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7761408      PMCID: PMC41800          DOI: 10.1073/pnas.92.11.4828

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Retroviral recombination during reverse transcription.

Authors:  D W Goodrich; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

2.  Comparison of mouse mammary tumor virus-specific DNA in inbred, wild and Asian mice, and in tumors and normal organs from inbred mice.

Authors:  V L Morris; E Medeiros; G M Ringold; J M Bishop; H E Varmus
Journal:  J Mol Biol       Date:  1977-07       Impact factor: 5.469

3.  A standardized nomenclature for endogenous mouse mammary tumor viruses.

Authors:  C Kozak; G Peters; R Pauley; V Morris; R Michalides; J Dudley; M Green; M Davisson; O Prakash; A Vaidya
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Genetic recombination of human immunodeficiency virus.

Authors:  F Clavel; M D Hoggan; R L Willey; K Strebel; M A Martin; R Repaske
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

5.  Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector.

Authors:  G M Shackleford; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

6.  Coexpression of exogenous and endogenous mouse mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range.

Authors:  T V Golovkina; A B Jaffe; S R Ross
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

7.  Novel class of mouse mammary tumor virus-related DNA sequences found in all species of Mus, including mice lacking the virus proviral genome.

Authors:  R Callahan; W Drohan; D Gallahan; L D'Hoostelaere; M Potter
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

8.  Endogenous mouse mammary tumor virus is expressed in several organs in addition to the lactating mammary gland.

Authors:  D Henrard; S R Ross
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

9.  A small region of the mouse mammary tumor virus long terminal repeat confers glucocorticoid hormone regulation on a linked heterologous gene.

Authors:  J Majors; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  Positive selection determines T cell receptor V beta 14 gene usage by CD8+ T cells.

Authors:  N S Liao; J Maltzman; D H Raulet
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

View more
  13 in total

1.  Both T and B cells shed infectious mouse mammary tumor virus.

Authors:  J L Dzuris; T V Golovkina; S R Ross
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 2.  On viruses, sex, and motherhood.

Authors:  L P Villarreal; L P Villareal
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

3.  Innate immune sensing of retroviral infection via Toll-like receptor 7 occurs upon viral entry.

Authors:  Melissa Kane; Laure K Case; Christine Wang; Leonid Yurkovetskiy; Stanislav Dikiy; Tatyana V Golovkina
Journal:  Immunity       Date:  2011-06-30       Impact factor: 31.745

4.  Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.

Authors:  T J Wrona; M Lozano; A A Binhazim; J P Dudley
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  C3H mouse mammary tumor virus superantigen function requires a splice donor site in the envelope gene.

Authors:  F Mustafa; M Lozano; J P Dudley
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Critical role of dendritic cells in mouse mammary tumor virus in vivo infection.

Authors:  Maria Cecilia Courreges; Dalia Burzyn; Irene Nepomnaschy; Isabel Piazzon; Susan R Ross
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

7.  Major histocompatibility complex class II I-E-independent transmission of C3H mouse mammary tumor virus.

Authors:  T Wrona; J P Dudley
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses.

Authors:  T V Golovkina; I Piazzon; I Nepomnaschy; V Buggiano; M de Olano Vela; S R Ross
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

Review 9.  Animal models of breast cancer for the study of pathogenesis and therapeutic insights.

Authors:  Angels Sierra
Journal:  Clin Transl Oncol       Date:  2009-11       Impact factor: 3.405

10.  Unconventional p97/VCP-Mediated Endoplasmic Reticulum-to-Endosome Trafficking of a Retroviral Protein.

Authors:  Wendy Kaichun Xu; Yongqiang Gou; Mary M Lozano; Jaquelin P Dudley
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.